PAR-23-109: NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to colleges and universities. Applications closed on August 8, 2025.
From the official notice on Grants.gov, last changed June 10, 2025. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeFM1
- Clinical trialsNot allowed
- Funded byNIAID, NHLBI, NEI
- Median yearly award$54,538
- Typical project length4 years
Projects funded under PAR-23-109 were run by National Institute of Allergy and Infectious Diseases (NIAID, 2 projects), National Heart Lung and Blood Institute (NHLBI, 2 projects), National Eye Institute (NEI, 1 project) and National Institute of Neurological Disorders and Stroke (NINDS, 1 project), and 3 more. Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-109 in the NIH Guide.
Key dates
| Posted | March 9, 2023 |
|---|---|
| Deadline | August 8, 2025 |
| Archived by Grants.gov | September 13, 2025 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the money in the 12 programs behind this notice (71% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of the MSPP is to develop a broad pool of combined-degree students (e.g., MD/PhD, DDS/PhD, DVM/PhD) who have conducted their PhD dissertation research at research laboratories in the NIH Intramural Research Program. The recipients will receive rigorous training in the basic, translational, and clinical biomedical sciences to prepare them for leadership positions in biomedical careers. The research and training plans are expected to provide the recipients with a strong understanding of the rigorous research study design, critical thinking, experimental methods and rigor, quantitative approaches, bioethics, and data analysis. Training also includes a mentored research experience, and extensive career and professional development, mentoring, and networking opportunities planned and supported by the program. This program thus provides the knowledge, professional skills, and experiences required to identify and transition into careers in the biomedical research workforce that utilize the combined degree.
Funded under PAR-23-109 so far
NIH funded 9 projects under PAR-23-109 in fiscal 2024 to 2026, at 8 institutions. The median yearly award was $54,538.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| MSPP Application: Investigating Tumor Evolution Using Integrative Multiomics Analysis and Computational Modeling | University of Maryland Baltimore | 2026 | $55,114 |
| MSPP Application for MD/PhD in Neurodegenerative Disease Research | University of South Florida | 2026 | $55,114 |
| SUNEEL BANERJEE PAR-23-109 APPLICATION | University of California, San Diego | 2026 | $49,538 |
| Track 1 NIH MD/PhD FM1 Application for Loh | University of Pittsburgh at Pittsburgh | 2026 | $55,114 |
| MSPP NIH MD/PhD Funding Application | University of California at Davis | 2026 | $55,114 |
| NIH MD/PhD Track 1 FM1 Application for Shah | Rutgers Biomedical and Health Sciences | 2026 | $55,114 |
| MSPP Application | Univ of North Carolina Chapel Hill | 2025 | $54,538 |
| Medical Scientist Partnership Program Fellowship for Varun Shenoy | Indiana University Indianapolis | 2025 | $54,538 |
Who has won Allergy and Infectious Diseases Research grants before
From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Washington | 85 | $938 million |
| Duke University | North Carolina | 230 | $781 million |
| University of California, Los Angeles | California | 138 | $745 million |
| The Johns Hopkins University | Maryland | 321 | $668 million |
| Emory University | Georgia | 282 | $650 million |
Who has won Aging Research grants before
From fiscal 2021 to 2025, Aging Research (93.866) awarded $19 billion across 11,026 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 337 | $575 million |
| The Trustees of Columbia University in the City of New York | New York | 242 | $574 million |
| University of Southern California | California | 203 | $572 million |
| The Washington University | Missouri | 210 | $556 million |
| Regents of the University of Michigan | Michigan | 232 | $538 million |
Who has won Cardiovascular Diseases Research grants before
From fiscal 2021 to 2025, Cardiovascular Diseases Research (93.837) awarded $15 billion across 11,798 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Pennsylvania | 313 | $380 million |
| Brigham & Womens Hospital Inc | Massachusetts | 274 | $374 million |
| Regents of the University of Michigan | Michigan | 277 | $355 million |
| The Trustees of Columbia University in the City of New York | New York | 207 | $335 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 295 | $320 million |
Other programs behind this notice
- Drug Use and Addiction Research Programs
- Vision Research
- National Center for Advancing Translational Sciences
- Human Genome Research
- Environmental Health
- Research Related to Deafness and Communication Disorders
- Cancer Research Manpower
- Lung Diseases Research
- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-109 still open?
No. It closed on August 8, 2025.
Who can apply for NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)?
Closed August 8, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-23-109?
NIH RePORTER lists 9 projects funded under PAR-23-109 in fiscal 2024 to 2026, at 8 institutions. The most were at University of Maryland Baltimore, University of South Florida, University of California, San Diego.
Who has won Environmental Health grants before?
The largest recipients over five fiscal years were Icahn School of Medicine at Mount Sinai, The Trustees of Columbia University in the City of New York, University of North Carolina at Chapel Hill. The program made 1,980 awards worth $2.1 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)